INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's Holding History (CIK: 0001132716)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 34,788 Value ($000) $32 Avg Close Range
Q4 2024
Shares 201,232 Value ($000) $557 Avg Close Range
Q3 2024
Shares 226,232 Value ($000) $1,183 Avg Close Range
Q2 2024
Shares 205,218 Value ($000) $915 Avg Close Range
Q1 2024
Shares 183,218 Value ($000) $1,403 Avg Close Range
Q4 2023
Shares 244,928 Value ($000) $1,043 Avg Close Range
Q3 2023
Shares 155,305 Value ($000) $652 Avg Close Range
Q2 2023
Shares 155,305 Value ($000) $865 Avg Close Range
Q1 2023
Shares 147,654 Value ($000) $846 Avg Close Range
Q3 2022
Shares 165,498 Value ($000) $444,000 Avg Close Range
Q2 2022
Shares 171,347 Value ($000) $817,000 Avg Close Range